A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1777-1788

  Yu, Min ^a   Johnson, Justin M ^a   Tuohy, Vincent K ^a,b  

^a Research Institute   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DEMYELINATION; EPITOPE MAPPING; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; CELL TRANSPLANTATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPE MAPPING; FEMALE; MICE; MOLECULAR SEQUENCE DATA; MYELIN PROTEOLIPID PROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; SELF TOLERANCE; SPINAL CORD; SPLEEN; T-LYMPHOCYTES; TIME FACTORS;

EID: 0029975898     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1777     Document Type: Article

References (54)

1. McCarron, R.M., R.J. Fallis, and D.E. McFarlin. 1990. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 29:73-79.
2. Clayton, J.P., G.M. Gammon, D.G. Ando, D.H. Kono, L. Hood, and E.E. Sercarz. 1989. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp. Med. 169:1681-1691.
3. Lehmann, P.V., T. Forsthuber, A. Miller, and E.E. Sercarz. 1992. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature (Lond.). 358:155-157.
4. Perry, L.L., E. Barzaga-Gilbert, and J.L. Trotter. 1991. T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalornyelitis J. Neuroimmunol. 33:7-15.
5. Cross, A.H., V.K. Tuohy, and C.S. Raine. 1993 Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol. 146:261-269.
6. McRae, B.L., C.L. Vanderlugt, M.C. Dal Canto, and S.D. Miller 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75-85.
7. Tuohy, V.K., Z. Lu, R.A. Sobel, R.A. Laursen, and M.B. Lees. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142: 1523-1526.
8. Milner, R.J., C. Lai, K.-A Nave, D. Lenoir, J. Ogata, and J.G. Sutcliffe. 1985. Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell. 42:931-939.
9. Macklin, W.B., C.W. Campagnoni, P.L. Deininger, and M.V. Gardinier. 1987. Structure and expression of the mouse myelin proteolipid protein gene. J. Neurosic. Res. 18:383-394.
10. Geysen, H.M., S.J.Rodda, T.J. Mason, G. Tribbick, and P.G. Schoofs. 1987. Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods 102:259-274.
11. Maeji, N.J., A.M. Bray, and H.M. Geysen. 1990. Multi-pin peptide synthesis strategy for T cell determinant analysis. J. Immunol. Methods, 134:23-33.
12. Gammon, G., H.M. Geysen, R.J. Apple, E. Pickett, M. Palmer, A. Ametani, and E.E. Sercarz. 1991. T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes. J. Med. 173:609-617.
13. 1s. J. Immunol. 152:3711-3719.
14. Kaufman, D.L., M. Clare-Salzler, J. Tian, T. Forsthuber, G.S. Ting, P. Robinson, M.A. Atkinson, E.E. Sercarz, A.J. Tobin, and P.V. Lehinann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (Lond.) 366:69-72.
15. Kono, D.H., J.L. Urban, S.J. Horvath, D.G. Ando, R.A. Saavedra, and L. Hood 1988. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J. Exp. Med. 168:213-227
16. Sakai, K., S.S. Zamvil, D.J. Mitchell, M. Lim, J.B. Rothbard, and L. Steinman. 1988. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic ohgopeptides of myelin basic protein. J. Neuroimmunol. 19:21-32.
17. Cross, A.H., G.A. Hashim, and C.S. Raine. 1991. Adoptive transfer of experimental allergic encephalomyehtis and localization of the encephalitogenic epitope in the SWR mouse. J. Neuroimmunol. 31:59-66.
18. Amor, A., D. Baker, N. Groome, and J.L. Turk. 1993. Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyehtis in Biozzi AB/H and nonobese diabetic mice. J. Immunol. 150:5666-5672.
19. Novotny, J., R.E. Bruccolen, W.D. Carlson, M. Handschumacher, and E. Haber. 1987. Antigenicity of myohemerythrin. Science (Wash. DC). 238:1584-1586.
20. Folch, J., M. Lees, and G.H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509.
21. Tuohy, V.K., and D.M. Thomas. 1995. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. J. Neuroimmunol. 56:161-170.
22. Gammon, G. and E. Sercarz. 1989. How some T cells escape tolerance induction. Nature (Lond.) 342:183-185.
23. Kearney, E.R., K.A. Pape, D.Y. Loh, and M.K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity. 1:327-339.
24. Oki, A., and E.E. Sercarz. 1985. T cell tolerance studied at the level of antigenic determinants. I. Latent reactivity to lysozyme peptides that lack suppressogenic epitopes can be revealed in lysozyme-tolerant mice. J. Exp. Med. 161:897-910.
25. th Int. Congr. Immunol. 848:5030 (Abstr.)
26. McRae, B.L., M.K. Kennedy, L.J. Tan, M.C. Dal Canto, K.S. Picha, and S.D. Miller. 1992. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogemc epitope of proteolipid protein. J. Neuroimmunol. 38:229-240.
27. Greer, J.M., V.K. Kuchroo, K.A. Sobel, and M.B. Lees. 1992. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149:783-788.
28. Greer, J.M., R.A. Sobel, A. Sette, M.B. Lees, and V.K. Kuchroo. 1994. Autoantigenic PLP peptides identified by MHC binding. J. Neuroimmunol. 54:165. (Abstr.)
29. 1 mice with acute experimental allergic encephalomyelitis induced with two different synthetic peptides of myelin proteolipid protein. J. Immunol. 146:543-549.
30. Beck, J., P. Rondot, L. Catinot, E. Falcoff, H. Kirchner, and J. Wietzerbin. 1988. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78:318-323.
31. Rieckmann, P., M. Albrecht, B. Kitze, T. Weber, H. Tumani, A. Broocks, W. Luer, A. Helwig, and S. Poser. 1995. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neural. 37:82-88.
32. Gijbels, K., J. Van Damme, P. Proost, W. Put, H. Carton, and A. Billiau. 1990. Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 20:233-235.
33. Baker, D., J.K. O'Neill, and J.L. Turk. 1991. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell. Immunol. 134: 505-510.
34. Merrill, J.E., D.H. Kono, J. Clayton, D.G. Ando, D.R. Hinton, and F.M. Hofman. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJI. and B10.PL mice. Proc. Natl. Acad. Sci. USA. 89:574-578.
35. Kennedy, M.K., D.S. Torrance, K.S. Picha, and K.M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496-2505.
36. Ransohoff, R.M., T.A. Hamilton, M. Tani, M.H. Stoler, H.E. Shick, J.A. Major, M.L. Estes, D.M. Thomas, and V.K. Tuohy. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:592-600.
37. Glabinski, A.R., M. Tani, V.K. Tuohy, R.J. Tuthill, and R.M. Ransohoff. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav. Immun. 9:315-330.
38. th Int. Cong. Immunol. 848: 678. (Abstr.)
39. Panitch, H.S., R.L. Hirsch, A.S. Haley, and K.P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet. i:893-895.
40. Pender, M.P., P.A. McCombe, G. Yoong, and K.B. Nguyen. 1992. Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J. Autoimmun. 5:401-410.
41. Critchfield, J.M., M.K. Racke, J.C. Zuniga-Pflucker, B. Cannella, C.S. Raine, J. Goverman, and M. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (Wash. DC). 263:1139-1143.
42. Vandenbark, A.A., G. Hashim, and H. Offner. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature (Lond.). 341:541-544.
43. Offner, H , G.A. Hashim, and A.A. Vandenbark. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science (Wash. DC). 251:430-432.
44. + T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909-916.
45. -/- mice. Science (Wash. DC). 256:1210-1213.
46. + cells in T cell receptor peptide-induced clonal unresponsiveness. Science (Wash. DC). 259:91-94.
47. Gammon, G., N. Shastri, J. Cogswell, S. Wilbur, S. Sadegh-Nasseri, U. Krzych, A. Miller, and E. Sercarz. 1987. The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site. Immunol. Rev. 98:53-73.
48. Cibotti, R., J.M. Kanellopoulos, J.-P. Cabaniols, O. Halle-Panenko, K. Kosmatopoulos, E. Sercarz, and P. Kourilsky. 1992. Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc. Natl. Acad. Sci. USA. 89:416-420
49. Sercarz, E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
50. Adorini, L., M.A. Harvey, A. Miller, and E.E. Sercarz. 1979. Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen eggwhite lysozyme in a genetically nonresponder mouse strain. J. Exp. Med. 150:293-306.
51. Maier, C.C., R.D. LeBoeuf, S.R. Zhou, J.N. Whitaker, M.A. Jarpe, and J.E. Blalock. 1993. The structure of a myelin basic protein-associated idiotope. J. Neuroimmunol. 46:235-243.
52. Hagerty, D.T., and P.M. Allen 1995. Intramolecular mimicry. Identification and analysis of two cross-reactive T cell epitopes within a single protein. J. Immunol. 155:2993-3001.
53. Filippi, M., M.A. Horsfield, S.P. Morrissey, D.G. Mac-Manus, P. Rudge, W.I. McDonald, and D.H. Miller. 1994. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology. 44:635-641.
54. Soderstrom, M., H. Link, S. Fredrikson, and J.-B. Sun. 1994. Optic neuritis and multiple sclerosis: the T cell repertoires to myelin proteins and MBP peptides change with time. Acta Neural. Scand. 90:10-18.